Cover Image
市場調查報告書

全球RNAi藥物遞輸市場

Global RNAi Drug Delivery Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 294953
出版日期 內容資訊 英文 45 Pages
訂單完成後即時交付
價格
Back to Top
全球RNAi藥物遞輸市場 Global RNAi Drug Delivery Market 2014-2018
出版日期: 2014年01月17日 內容資訊: 英文 45 Pages
簡介

全球RNAi(RNA干擾)藥物遞輸市場,預計從2013年到2018年期間以21.80%的年複合成長率擴大。RNA治療藥開發的增加為這個成長的背景。在還有該市場中,也可見幾個主要技術的發展。

本報告提供全球RNAi藥物遞輸市場現狀與其預測、市場成長因素與課題、主要供應商的資訊等等,為您概述為以下內容。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 提供技術

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 市場區隔

  • 概要

第8章 地理區分

第9章 購買標準

第10章 市場成長因素

第11章 成長因素與其影響

第12章 市場課題

第13章 成長因素與課題的影響

第14章 市場趨勢

第15章 趨勢與其影響

第16章 業者情勢

  • 競爭模式
    • 主要消息
    • 有力供應商

第17章 主要供應商分析

  • Alnylam Pharmaceuticals Inc.
  • Isis Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Tekimira Pharmaceuticals Corp.

第18章 相關報告

目錄
Product Code: IRTNTR3186

TechNavio's analysts forecast the Global RNAi Drug Delivery market to grow at a CAGR of 21.80 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in RNA therapeutic development. The Global RNAi Drug Delivery market has also been witnessing some key technological advancements. However, the targeted delivery of RNA molecules is expected to pose a challenge to the growth of this market.

TechNavio's report, the Global RNAi Drug Delivery Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global RNAi Drug Delivery market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space are Alnylam Pharmaceuticals Inc., Isis Pharmaceuticals, Inc.,Merck & Co. Inc., and Tekmira Pharmaceuticals Corp..

Other vendors mentioned in the report are Access Pharmaceuticals Inc., Calondo Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Marina Biotech Inc., PhaseRx Inc., Quark Pharmaceuticals Inc., RXi Pharmaceuticals Corp., Silence Therapeutics plc, Sirnaomics Inc., Tacere Therapeutics Inc., and Traversa Therapeutics Inc.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Technology Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation

  • 07.1. Overview

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Alnylam Pharmaceuticals Inc.
    • 17.1.1. Business Overview
    • 17.1.2. Key Information
    • 17.1.3. SWOT Analysis
  • 17.2. Isis Pharmaceuticals Inc.
    • 17.2.1. Business Overview
    • 17.2.2. Key Information
    • 17.2.3. SWOT Analysis
  • 17.3. Merck & Co. Inc.
    • 17.3.1. Business Overview
    • 17.3.2. Business Segmentation
    • 17.3.3. Key Information
    • 17.3.4. SWOT Analysis
  • 17.4. Tekimira Pharmaceuticals Corp.
    • 17.4.1. Business Overview
    • 17.4.2. Key Information
    • 17.4.3. SWOT Analysis

18. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global RNAi Drug Delivery Market 2013-2018 (US$ billion)
  • Exhibit 3: Global RNAi Drug delivery market-Segmentation by Types
  • Exhibit 4: Global RNAi drug delivery Market By Types 2013
  • Exhibit 5: Global RNAi Drug Delivery Market By Geography 2013
  • Exhibit 6: Business Segmentation of Merck& Co. Inc.
Back to Top